Clinique Anti-Blemish Solutions Clearing Concealer is a medicated concealer that helps clear and prevent blemishes. This medicated concealer contains a gentle. soothing formula that provides natural-looking coverage as blemishes heal. It’s offered in three skintone shades and can be worn alone. under makeup. or used for touch-ups. Plus. it has a green tint to visually correct redness under makeup. This oil-free concealer blends evenly and provides a smooth. matte. natural-looking finish.
- Anti-Blemish Solutions is a skincare line by Clinique that is specifically formulated to target acne and breakouts. helping to clear up existing blemishes and prevent new ones from forming.
- The line includes a range of products such as a cleansing foam. clarifying lotion. all-over clearing treatment. and spot treatment. which work together to help reduce the appearance of blemishes and promote a clearer. healthier-looking complexion.
- One of the key ingredients in the Anti-Blemish Solutions line is salicylic acid. a beta-hydroxy acid that helps to unclog pores and exfoliate the skin. Other ingredients include witch hazel. tea tree oil. and benzoyl peroxide. all of which are known for their acne-fighting properties.
- The Anti-Blemish Solutions line is suitable for all skin types. including sensitive skin. Clinique recommends using the products as part of a daily skincare routine. with the cleansing foam and clarifying lotion used twice a day. and the clearing treatment and spot treatment applied as needed.
- Many users of Anti-Blemish Solutions have reported significant improvements in their skin. with reduced breakouts. fewer blemishes. and a smoother. more even complexion. However. as with any skincare product. results may vary and it’s important to follow the recommended usage instructions and consult with a dermatologist if you have any concerns about your skin.
Specifications
Features | concealers-makeup |
Brand | Clinique |
Assembled Product Dimensions (L x W x H) | 1.00 x 1.00 x 1.00 Inches |
Reviews
There are no reviews yet.